国际标准期刊号: E-2314-7326
P-2314-7334

神经传染病

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Current Updates on the Diagnosis and Management of Multiple Sclerosis for General Neurologists

Hernan Voigt

Multiple sclerosis (MS) is a complex autoimmune disorder of the central nervous system, characterized by demyelination, inflammation, and axonal damage. Over the years, significant progress has been made in understanding the pathophysiology, diagnosis, and management of MS. This abstract provides an overview of the current updates in the diagnosis and management of MS, aimed at general neurologists. In recent years, advancements in neuroimaging techniques, particularly magnetic resonance imaging (MRI), have greatly improved the early diagnosis and monitoring of MS. Revised diagnostic criteria, such as the 2017 McDonald criteria, have enhanced the accuracy and efficiency of MS diagnosis. Moreover, the discovery of specific biomarkers has shown promise in aiding early diagnosis and predicting disease progression. The treatment landscape for MS has also evolved substantially. Disease-modifying therapies (DMTs) remain the cornerstone of MS management, with an expanding array of options available, including oral, injectable, and infusion-based medications. Personalized treatment plans, guided by factors such as disease activity, patient preferences, and potential side effects, have become increasingly important in optimizing patient outcomes. Additionally, symptomatic management and rehabilitation strategies have gained prominence in improving the quality of life for MS patients. Emerging therapies targeting neuroprotection and demyelination offer hope for addressing the long-term disability associated with the disease. This abstract underscores the importance of staying updated with the latest developments in the field of MS diagnosis and management, as early intervention and tailored treatment plans are crucial in improving patient outcomes and minimizing disease-related disability. General neurologists play a vital role in the multidisciplinary care of MS patients, and their understanding of current updates is essential in providing the best possible care.